Is Neoleukin Therapeutics, Inc. (NLTX) a Buy, Sell, or Hold?
NASDAQ : NLTX
Neoleukin Therapeutics, Inc. — Competitors
$3.49 USD
$0.05 (1.45%)
- Volume
- 109.1K
- Average Volume
- 6.08K
- Market Capitalization
- $8.2M
- P/E Ratio
- -4.42
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $18.80
- Year Low
- $3.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.64
NLTX vs. The Competition
| Properties | NLTX | BIOR | CHRO | CNTG |
|---|---|---|---|---|
| Market Cap | $8.2M | $994.99K | $8.9M | $9.42M |
| Shares Outstanding | $2.35M | $4.52M | $6.6M | $28.98M |
| P/E Ratio | -4.42 | -0.0 | -0.05 | -0.22 |
| EPS | -4.93 | -78.69 | -15.58 | -1.26 |
| Day Low | 3.42 | 0.22 | 1.2301 | 0.325 |
| Day High | 3.59 | 0.22 | 1.48 | 0.325 |
| Year Low | 3.42 | 0.15 | 1.2301 | 0.325 |
| Year High | 18.8 | 0.3802 | 54.29 | 0.429 |
| Average Price 50 | 13.8252 | 0.22 | 12.02644 | 0.16441 |
| Average Price 200 | 14.98338 | 0.22 | 12.00079 | 0.2557 |
| Volume | 109.1K | 169.45K | 193.12K | 7.23M |
| Average Volume | - | - | - | - |